论文部分内容阅读
目的:观察参芪扶正注射液(丽珠集团利民制药厂,批号:051290)在减轻肿瘤化疗毒副作用中的临床疗效。方法:回顾性收集笔者近5年收治可评价的恶性肿瘤患者90例,按数字表法随机分为单纯化疗组(对照组)和化疗+参芪扶正注射液组(观察组),比较两组患者化疗后的毒副反应。结果:在提高生活质量方面:观察组有效率为88.89%,对照组有效率为66.67%,两组间有效率比较具有显著性差异(P<0.05)。在减轻毒副反应方面:观察组有效率为82.22%,对照组有效率为60.00%,两组间有效率比较具有显著性差异(P<0.05)。结论:参芪扶正注射液有提高生活质量,减轻化疗毒副作用的功能。
Objective: To observe the clinical efficacy of Shenqi Fuzheng Injection (Livzon Pharmaceutical Group, Limin Pharmaceutical Group, batch number: 051290) in reducing the toxic and side effects of chemotherapy. Methods: A retrospective collection of 90 patients with malignant tumor admitted to the hospital in the past 5 years were randomly divided into chemotherapy group (control group) and chemotherapy + Shenqi Fuzheng injection group (observation group) according to the digital table method. Toxicity of patients after chemotherapy. Results: In improving quality of life, the effective rate was 88.89% in the observation group and 66.67% in the control group, with significant difference between the two groups (P <0.05). In reducing the side effects, the effective rate of the observation group was 82.22%, while that of the control group was 60.00%. There was significant difference between the two groups (P <0.05). Conclusion: Shenqi Fuzheng injection can improve the quality of life and reduce the toxic side effects of chemotherapy.